Information  X 
Enter a valid email address

Vectura Group plc (VEC)

  Print      Mail a friend

Tuesday 17 September, 2019

Vectura Group plc

Holdings in Company

RNS Number : 5827M
Vectura Group plc
17 September 2019
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

TR-1 : NOTIFICATION OF MAJOR INTEREST IN SHARES

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Vectura Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to the
notification obligation:
iii

HBM Healthcare Investments (Cayman) Ltd.

4. Full name of shareholder(s)
 (if different from 3.):iv

Morestan Nominees Ltd A/C SEG

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

13 September 2019

6. Date on which issuer notified:

16 September 2019

7. Threshold(s) that is/are crossed or
reached:
vi, vii

4%

         
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect



GB00B01D1K48

33,121,166

33,121,166

26,449,301

26,449,301

-

3.969552883

-

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

26,449,301

3.969552883%

                               
 

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

HBM Healthcare Investments AG (parent company)

N/a

N/a

N/a

HBM Investments (Cayman) Limited (wholly-owned subsidiary)

N/a

N/a

N/a

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A

 


13. Additional information:


N/A

14. Contact name:

Jean-Marc Lesieur

15. Contact telephone number:

+1 345 946 8003

           

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
HOLGIGDCGGBBGCR

a d v e r t i s e m e n t